Loading...

CRISPR Therapeutics AG

CRSP•NASDAQ
Healthcare
Biotechnology
$64.76
$-1.30(-1.97%)

CRISPR Therapeutics AG (CRSP) Stock Chart & Performance Analysis

Explore CRISPR Therapeutics AG’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-1.81%
5-Day Change
7.23%
1-Month Change
-20.95%
3-Month Change
-13.68%
6-Month Change
-24.52%
Year-to-Date (YTD) Change
-17.31%
1-Year Change
-44.51%
3-Year Change
-44.25%
5-Year Change
-25.54%
All-Time (Max) Change
143.15%

Analyzing CRISPR Therapeutics AG (CRSP) Trends Across Multiple Time Frames

CRISPR Therapeutics AG Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. CRISPR Therapeutics AG stock shows -1.81% 1-day change, indicating low volatility, while its 5-day change of 7.23% suggests a broader trend. Over a 1-month period, a -20.95% drop could signal a pullback, whereas a 3-month decline of -13.68% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -24.52% and a YTD drop of -17.31% might concern investors, but a 1-year loss of -44.51% and a 3-year drop of -44.25% could indicate resilience. The 5-year surge of -25.54% highlights weak historical growth, while the all-time return of 143.15% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;